Abstract:Antibody-dependent cellular phagocytosis (ADCP) has been implicated in protection against HIV-1. However, methods for measuring ADCP currently rely on the phagocytosis of gp120- or gp41-coated beads that do not reflect physiologically relevant conformations of the viral envelope glycoprotein or the size of a virus-infected cell. We therefore developed a novel approach for measuring ADCP of HIV-infected cells expressing natural conformations of Env. A monocytic cell line (THP-1 cells) or primary human monocytes were incubated with a CD4+ T cell line that expresses eGFP upon HIV-1 infection in the presence of antibodies and ADCP was measured as the accumulation of eGFP+ material by flow cytometry. The internalization of HIV-infected cells by monocytes was confirmed visually by image-capture flow cytometry. Cytoskeletal remodeling, pseudopod formation and phagocytosis were also observed by confocal microscopy. We found that potent broadly neutralizing antibodies (bnAbs), but not non-neutralizing antibodies (nnAbs), mediate efficient phagocytosis of cells infected with either primary or lab-adapted HIV-1. A nnAb to a CD4-inducible epitope of gp120 (A32) failed to enable ADCP of HIV-infected cells but mediated efficient phagocytosis of gp120-coated beads. Conversely, a bnAb specific to intact Env trimers (PGT145) mediated potent ADCP of HIV-infected cells but did not facilitate the uptake of gp120-coated beads. These results underscore the importance of measuring ADCP of HIV-infected cells expressing physiologically relevant conformations of Env and show that most antibodies that are capable of binding to Env trimers on virions to neutralize virus infectivity are also capable of binding to Env on the surface of virus-infected cells to mediate ADCP. In addition to neutralizing virus-infectivity, antibodies that bind to the human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) can recruit cells of the immune system to eliminate productively infected cells through a process known as antibody-dependent cellular phagocytosis (ADCP). ADCP occurs when an antibody bound to Env on the surface of an HIV-infected cell is recognized by a phagocytic cell, such as a monocyte, macrophage or neutrophil, and the phagocytic cell engulfs and destroys the virus-infected cell. ADCP has been implicated in protection against HIV-1. However, methods for measuring ADCP currently do not reflect physiologically relevant conformations of Env or the size of a virus-infected cell. We therefore developed a novel assay for measuring ADCP of HIV-infected cells expressing natural conformations of Env. Using this approach, we found that potent broadly neutralizing antibodies (bnAbs) that are capable of binding to functional Env trimers on virions to block HIV-1 infectivity can also mediate efficient phagocytosis of HIV-infected cells. However, non-neutralizing antibodies (nnAbs) that by definition cannot block viral infectivity exhibit little or no ADCP. These results stand in marked contrast to previous methods for measuring ADCP based on the internalization of beads coated with recombinant Env proteins, which show greater antibody-dependent phagocytosis by nnAbs. These results show that most antibodies that are able to neutralize HIV-1 infectivity are also able to direct the phagocytosis of HIV-infected cells and illustrate the importance of measuring ADCP of virus-infected cells expressing physiologically relevant conformations of Env.

An Anti-Hiv-1 Gp120 Antibody Expressed As an Endocytotic Transmembrane Protein Mediates Internalization of HIV-1.

Gp120 Binding with DC-SIGN Induces Reactivation of HIV-1 Provirus Via the NF-κB Signaling Pathway

Antibody-Mediated Internalization of Infectious Hiv-1 Virions Differs among Antibody Isotypes and Subclasses

Intra- and Extracellular Immunization Against HIV-1 Infection with Lymphocytes Transduced with an AAV Vector Expressing a Human Anti-gp120 Antibody

Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55(gag) precursor protein

Engineering And Functional Evaluation Of A Single-Chain Antibody Against Hiv-1 External Glycoprotein Gp120

Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells

Small-molecule Inhibitors of HIV-1 Entry Block Receptor-Induced Conformational Changes in the Viral Envelope Glycoproteins.

Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms

Human Immunodeficiency Virus 1 Preferentially Fuses with pH-Neutral Endocytic Vesicles in Cell Lines and Human Primary CD4+ T-Cells

[A Non-Infectious and Quantitative Cell-Based Bioassay for Screening HIV Entry Inhibitors Targeting HIV Envelope Proteins].

Construction of Recombinant Plasmid and Expression of Surface Glycopro- Tein Gp120 of HIV-1

An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Biological Function Of Hiv-1 Transmembrane Protein Gp41 - A Study On A Putative Cellular Receptor Of Gp41

A multi-functional peptide as an HIV-1 entry inhibitor based on self-concentration, recognition, and covalent attachment.

Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.

Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.

Vaccine-induced HIV-1 Envelope Gp120 Constant Region 1-Specific Antibodies Expose a CD4-inducible Epitope and Block the Interaction of HIV-1 Gp140 with Galactosylceramide.

Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry

Antibodies to Several Conformation-Dependent Epitopes of Gp120/gp41 Inhibit CCR-5-dependent Cell-to-cell Fusion Mediated by the Native Envelope Glycoprotein of a Primary Macrophage-Tropic HIV-1 Isolate